BackKORU Medical Systems Overview

KORU Medical Systems Operating Income

Track KORU Medical Systems's operating income ($-640K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly Operating Income

$626991.00
300.54% YoY

As of Jun 30, 2026

Annual Operating Income (TTM)

$-644683.00
85.37% YoY

Trailing 12 months ending Jun 30, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

KORU Medical Systems (KRMD) FAQ

KORU Medical Systems's operating income stands at $-640K as of June 2026. That compares with $-4.4M in the prior-year period — up 85.4% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

KORU Medical Systems reported $-640K in operating income versus $-4.4M a year earlier — a 85.4% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $-4.4M in the prior-year period — up 85.4% year over year. Sustained growth in operating income can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how KORU Medical Systems's operating income evolved across reporting periods, while the comparison chart places KRMD next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, operating income is commonly used to spot outliers. KORU Medical Systems's reading of $-640K is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.